These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6276299)

  • 21. Thalidomide-induced severe facial erythema in a patient with hepatocellular carcinoma.
    Chiou CC; Shih IH; Chang YC; Lee JC; Kuo SC; Hong HS; Yang CH
    Int J Clin Pract; 2007 Aug; 61(8):1415-7. PubMed ID: 17627717
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect and pharmacokinetics of etoposide in patients with primary hepatocellular carcinoma].
    Funakoshi S; Aiba K; Dobashi F; Inamoto Y; Hirano A; Tada N; Ogihara A; Fujii T; Kuraishi Y; Yamada T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):165-7. PubMed ID: 8380686
    [No Abstract]   [Full Text] [Related]  

  • 23. Interferon for postresection recurrence of hepatocellular carcinoma.
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2002 Dec; 97(12):3200-2. PubMed ID: 12492213
    [No Abstract]   [Full Text] [Related]  

  • 24. [Can adjuvant chemotherapy of hepatocellular carcinoma improve results of liver transplantation?].
    Burtin P
    Gastroenterol Clin Biol; 1993; 17(10):776-7. PubMed ID: 8288099
    [No Abstract]   [Full Text] [Related]  

  • 25. Octreotide treatment of hepatocellular carcinoma.
    Kouroumalis E; Samonakis D; Skordilis P
    Hepatology; 2003 Feb; 37(2):477. PubMed ID: 12540801
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatocellular carcinoma--a chemosensitive tumor?].
    Kubicka S; Malek NP; Zender L
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S115-7. PubMed ID: 12817342
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant interferon for hepatocellular carcinoma.
    Okada S; Sato T; Yamamoto S
    Hepatology; 2001 Feb; 33(2):481-2. PubMed ID: 11172357
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of hepatocellular carcinoma with tamoxifen].
    Raoul JL
    Gastroenterol Clin Biol; 1996 Mar; 20(2):221-2. PubMed ID: 8761695
    [No Abstract]   [Full Text] [Related]  

  • 29. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
    Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tamoxifen and hepatocellular carcinoma: verdict after enthusiasm...].
    Barbare JC
    Gastroenterol Clin Biol; 1996; 20(6-7):609-10. PubMed ID: 8881581
    [No Abstract]   [Full Text] [Related]  

  • 31. Low-dose methotrexate therapy for hepatoblastoma.
    Weitman SD; Kato GJ; Barbosa JL; Kamen BA
    Cancer Chemother Pharmacol; 1991; 28(3):233-4. PubMed ID: 1649707
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunotherapy of hepatocellular carcinoma.
    Greten TF; Manns MP; Korangy F
    J Hepatol; 2006 Dec; 45(6):868-78. PubMed ID: 17046096
    [No Abstract]   [Full Text] [Related]  

  • 33. A new approach to therapy for hepatocellular carcinoma?
    Harrison SA; Di Bisceglie AM
    Hepatology; 2003 Feb; 37(2):471-3. PubMed ID: 12540798
    [No Abstract]   [Full Text] [Related]  

  • 34. Thalidomide for advanced hepatocellular carcinoma: is this a real alternative?
    Wadler S
    Cancer; 2005 Jan; 103(1):1-4. PubMed ID: 15565637
    [No Abstract]   [Full Text] [Related]  

  • 35. Megestrol treatment in patients with hepatocellular carcinoma.
    Farinati F; Gianni S; De Giorgio M; Fiorentini S
    Br J Cancer; 2001 Nov; 85(10):1606-8. PubMed ID: 11720452
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidemiology of primary hepatic malignancies in U.S. children.
    Darbari A; Sabin KM; Shapiro CN; Schwarz KB
    Hepatology; 2003 Sep; 38(3):560-6. PubMed ID: 12939582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute tumor lysis syndrome after thalidomide therapy in advanced hepatocellular carcinoma.
    Lee CC; Wu YH; Chung SH; Chen WJ
    Oncologist; 2006 Jan; 11(1):87-8; author reply 89. PubMed ID: 16401719
    [No Abstract]   [Full Text] [Related]  

  • 38. Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma.
    Rizzi PM; Ryder SD; Ramage JK; Gane E; Karani J; Heaton N; Portmann B; Tan KC; Williams R
    Transplant Proc; 1994 Dec; 26(6):3568-9. PubMed ID: 7527979
    [No Abstract]   [Full Text] [Related]  

  • 39. Polyprenoic acid in hepatocellular carcinoma.
    Decensi A; Costa A
    N Engl J Med; 1996 Nov; 335(19):1461; author reply 1461-2. PubMed ID: 8927082
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of chemotherapy in hepatocellular carcinoma with liver cirrhosis].
    Munehisa T; Tajima H; Goto M; Nakata K; Muro T; Kawahara K; Kohno K; Sato A; Furukawa R; Ogino T
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2318-23. PubMed ID: 6314913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.